Bioby Biogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioby Biogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioby Biogen Today - Breaking & Trending Today

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion

Published: May 29, 2024

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical progress

Source: finanznachrichten.de

Related Topics:

France GeneralUnited StatesNew YorkJessica FadelTony AdamisAndreas WallnoeferBain Capital Life SciencesMerck CoSv Health InvestorsBiogen IncEyebiotech Limited EyebioJeito CapitalEyebiotech LimitedHart Scott Rodino Antitrust Improvements ActSamsara BiocapitalOmega FundsVertex VenturesAnti Permeability MechanismAge Related Ocular Neovascularization EvaluationBioby BiogenChief Executive OfficerJane ElliottDavide SalviIhr Portfolio